GlaxoSmithKline PLC (GSK)
GlaxoSmithKline PLC (GSK)
$40.19 USD
Updated Aug 16 12:00am
Add GSK to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
GSK Stock Chart More Charts
GSK Price/Volume Stats
| Current price | $40.19 |
| Prev. close | $39.96 |
| Day low | $40.15 |
| Day high | $40.38 |
| 50-day MA | $40.69 |
| 200-day MA | $40.04 |
| 52-week high | $42.47 |
| 52-week low | $36.41 |
| Volume | 1,367,100 |
| Avg. volume | 2,595,579 |
| Dividend yield | 4.55% |
| Market Cap | 99.70B |
GlaxoSmithKline PLC (GSK) Company Bio
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The companys wellness products include Panadol and Panadol Cold & Flu, ENO and Tums - antacids, and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate - treatment of nicotine withdrawal, Sensodyne - to ttreat and prevent dental sensitivity, Polident, Poligrip, and Corega to enhance comfort of fitted denture, and Aquafresh for the prevention of gum disease and bad breath. The company was founded in 1935 and is based, the United Kingdom.
Top Stories View All
Sweet 16 Safe Stocks for this Volatile Market
Does 1 Equation Hold the Key for Stock Prices?
Best & Worst Performing Stock Industries for August 16, 2019
Best & Worst Performing Small Cap Stocks for August 16, 2019
Best & Worst Performing Mid Cap Stocks for August 16, 2019
View All Top Stories
Loading social stream, please wait...